Navigation Links
Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
Date:4/29/2008

ceuticals

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

Alexza has six product candidates in clinical development. Alexza's lead program, AZ-004 (Staccato loxapine) for the treatment of acute agitation in schizophrenic or bipolar disorder patients, is in Phase 3 testing. AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches has completed Phase 2 testing. AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches and AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. Product candidates in Phase 1 testing include AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with Endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releases from Alexza is available online at http://www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the development, therapeutic potential and safety of AZ-007. Any statement describing a product candidate or Alexza's goals, expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and u
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... TWi Pharmaceuticals, Inc. (4180.TT) today announced that ... States Food and Drug Administration (FDA) on its ... 125mg/ml oral suspension, the generic equivalent to Par ... under Hatch Waxman rules, it will be entitled ... completed the pre-launch preparation of the generic drug.  ...
(Date:8/27/2014)... Columbia and MENLO PARK, Calif. ... Inc. , (OTCQB: DMPI), developer of advanced cancer ... at the 16th Annual Rodman & Renshaw Global Investment ... LLC. The presentation will take place Tuesday, September 9th at ... floor) at the New York Palace Hotel in ...
(Date:8/27/2014)... 27, 2014 Varian Medical Systems (NYSE: VAR) today broke ... Salt Lake City manufacturing facility and allow ... Utah to ultimately create 1,000 new full ... " Utah is home ... of whom can be credited with Varian,s success in the ...
Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4
... Nfocus Neuromedical, Inc., an innovative medical device company ... brain aneurysms, today announced that the company received U.S. ... Vessel Occlusion System (VOS).  The Acta VOS provides physicians ... an array of common and potentially serious vascular lesions. ...
... 11, 2011 Reportlinker.com announces that a new ... Novo Nordisk A/S: PharmaVitae Profile ... Introduction This analysis ... Nordisk in the prescription pharmaceutical sector. The profile ...
Cached Medicine Technology:Nfocus Neuromedical Announces FDA 510(k) Clearance for Next Generation Device to Treat Vascular Lesions 2Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 2
(Date:8/27/2014)... For those who want to build ... products are very practical. Top10BestSEOHosting.com today announces that ... the best ASP.NET hosting suppliers of this year. ... top web hosting provider for a long time, ... today. Recently proclaimed one of the fastest growing ...
(Date:8/27/2014)... Arrow, OK (PRWEB) August 27, 2014 When ... their guests a comfortable bed to sleep without breaking the ... the market for a new foam mattress set for the ... to sleep on, Bedding Mart has it all during their ... stock up on some of the best mattresses for the ...
(Date:8/27/2014)... Charlotte, NC (PRWEB) August 27, 2014 Taking ... extremes, the Steele Creek YMCA will host its ... Race on Saturday, September 13 at YMCA Camp ... in three race divisions: adult, youth and teams. Within ... pushing themselves to their physical limit - for a worthy ...
(Date:8/27/2014)... Canada Goose Parkas from CanadaGooseJackor.nu are great. By ... With unique detailing such as buttons, leather trim and a ... in opulence. Recently, the company has unveiled its new range ... , True enough, the new assortment comes in various popular ... off) on all these brand new items. By launching the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The New ... ) is holding free events about “ Sexuality & ... Liz Treston. These straightforward and entertaining discussions are for ... Bussani Mobility (501 Concord Avenue, Mamaroneck, NY) and October ... Avenue, Bethpage, NY). , The New York Mobility ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2
... fiber is perhaps the first thing that doctors and ... a condition characterized by enlargement of blood vessels, in ... bleeding and uneasiness. ,According to the American Society ... by a variety of factors, including pregnancy, chronic constipation ...
... U.S President Bill Clinton is on a different trip. Bill Clinton ... grew up on rich, fat laden diets that did not even ... serious health trouble, leading to a major bypass surgery. Now, with ... with a motive to make the future generation, a leaner lot! ...
... blue Smarties will no longer fascinate kids after maker ... from them//. Nestlé said that it was only reacting ... that the artificial color could harm children. ... coloring was the one, which was most likely to ...
... billion for providing a nutritious diet to undernourished women ... the previous year. ,The main beneficiary would ... who will get the supplementary nutritious diet from mother ... and child welfare department official. ,The state's ...
... diet not only makes you slim, it may help ... Leeuwenburgh and other scientists from the University of Florida's ... calories a day and moderately increased the animals' activity. ... their average and significantly overturned the negative effects of ...
... have near normal lung function and seem to perform ... cancer patients//. Similarly, male lung cancer patients were likely ... which is characterized by progressive deterioration in lung function. ... the CHEST journal, a publication of the American College ...
Cached Medicine News:Health News:Male Lung Cancer Patients Less Likely To Perform Well in Lung Function Tests 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: